Compared with control, 10, 20, and 40 g/kg BPC-157 suppressed the flinches during the 1st phase but did not suppress the flinches during the 2nd phase
While most people notice symptoms associated with low nutrients, it can vary and isn't always intuitive
Podemos encontrar estudios en los que se pone por las nubes como si fuera el milagro antigrasa a la hora de adelgazar o como el suplemento capaz de hacer que nuestro cuerpo rinda casi en exclusiva a partir de grasas, y otros muchos estudios en los que se dice que no retrasa la fatiga en el ejercicio, ni afecta al VO2mx , ni consigue mejorar el metabolismo de las grasas
doi: 10.1038/s41591-023-02260-4
61 ECC5004 The preliminary results of the investigational agent ECC5004 phase 1 trial in non-human primates revealed a reduction in HbA1c levels, accompanied by weight loss and a decreased risk of adverse cardiovascular events, achieved through the mimicry of the hormone GLP-1
In contrast, gastrointestinal side effects were reported in 10 of the 11 studies and were consistently more common in the intervention groups
